Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
This Week in Biotech
Motley Fool
Sat, 11/16/13 - 01:23 pm
Tags:
Vanda
,
Cadence Pharmaceuticals
,
Immunogen
,
Novartis
,
Pharmacyclics
,
JNJ
,
Epizyme
,
Sarepta Therapeutics
,
GSK
Experimental bird flu vaccines show promise in early trials
Yahoo/Reuters
Thu, 11/14/13 - 08:57 am
Tags:
bird flu
,
Novartis
,
vaccines
,
Novavax
,
H7N9
Why Big Pharma Is Breaking Up
Motley Fool
Wed, 11/13/13 - 08:29 am
Tags:
Merck
,
Novartis
,
Big Pharma
,
Abbott Labs
,
AbbVie
,
Pfizer
,
Zoetis
Novartis: Transfusion Tests Sale Does Not Point To Further Divestments
Seeking Alpha
Mon, 11/11/13 - 10:36 pm
Tags:
Novartis
,
M&A
,
Grifols
Novartis sells blood transfusion test unit to Grifols for $1.7 billion
Yahoo/Reuters
Mon, 11/11/13 - 10:21 am
Tags:
Novartis
,
M&A
,
blood transfusions
,
Grifols
Make A Suave Move, Buy Novartis
Seeking Alpha
Sat, 11/9/13 - 12:40 pm
Tags:
Novartis
A Busy Day of Layoffs in Pharma
Motley Fool
Fri, 11/8/13 - 12:00 pm
Tags:
layoffs
,
Novartis
,
Bristol-Myers Squibb
,
Ariad Pharmaceuticals
Novartis to add 175 jobs in Cambridge, cut elsewhere
Boston Globe, MA
Thu, 11/7/13 - 08:15 am
Tags:
Novartis
,
Boston
,
restructuring
Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wed, 11/6/13 - 10:39 am
Tags:
GSK
,
Bayer
,
Sanofi
,
Novartis
,
JNJ
,
Bristol-Myers Squibb
,
Merck
,
AbbVie
,
Eli Lilly
,
Pfizer
,
AstraZeneca
Novartis plots sales cuts in U.K. amid R&D restructuring
Fierce Pharma
Wed, 11/6/13 - 08:27 am
Tags:
UK
,
R&D
,
Novartis
,
layoffs
Novartis chopping 371 research jobs in global R&D shakeup
Fierce Biotech
Tue, 11/5/13 - 11:12 am
Tags:
Novartis
,
R&D
,
layoffs
Novartis Said to Mull Animal-Health Sale in Asset Review
Bloomberg
Tue, 11/5/13 - 08:20 am
Tags:
Novartis
,
animal health
Novartis Faces Criminal Complaint Over Diovan Research In Japan
Pharmalot
Mon, 11/4/13 - 10:04 am
Tags:
Novartis
,
Diovan
,
R&D
,
Japan
Tecfidera Succeeds in Protecting Biogen's MS Market Share From Novartis' Gilenya
Motley Fool
Sun, 11/3/13 - 12:12 pm
Tags:
Gilenya
,
Novartis
,
MS
,
multiple sclerosis
,
Biogen Idec
,
Tecfidera
Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment
Seeking Alpha
Thu, 10/31/13 - 09:38 am
Tags:
Pfizer
,
Novartis
,
breast cancer
,
palbociclib
,
LEE011
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
Tags:
patents
,
Copaxone
,
Teva
,
Nexium
,
AstraZeneca
,
Micardis
,
Boehringer Ingelheim
,
Sandostatin LAR
,
Novartis
,
Exforge
,
Nasonex
,
Merck
,
TriLipix
,
AbbVie
,
Evista
,
Eli Lilly
,
Restasis
,
Allergan
,
Renagel
,
Sanofi
Novartis' Pharmaceutical Business Faces 2 Major Challenges
Motley Fool
Fri, 10/25/13 - 09:41 am
Tags:
Novartis
,
Gilenya
,
Tecfidera
,
GSK
,
Seebri Breezhaler
,
COPD
,
Xolair
Novartis shares climb after drug maker says it may sell small assets
Marketwatch
Tue, 10/22/13 - 12:49 pm
Tags:
Novartis
Novartis grabs an option to buy biotech startup for up to $300M
Fierce Biotech
Tue, 10/22/13 - 11:43 am
Tags:
M&A
,
Novartis
,
SP-420
,
Sideris Pharmaceuticals
Novartis Raises 2013 Forecast on Lack of Diovan Generic
Bloomberg
Tue, 10/22/13 - 08:11 am
Tags:
Novartis
,
guidance
,
Diovan
Pages
« first
‹ previous
…
103
104
105
106
107
108
109
110
111
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.